Skip to content
VuFind
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
Advanced
  • Correction to “Targeting the S...
  • Cite this
  • Text this
  • Email this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
  • Permanent link
Correction to “Targeting the Spike: Repurposing Mithramycin and Dihydroergotamine to Block SARS-CoV‑2 Infection”

Correction to “Targeting the Spike: Repurposing Mithramycin and Dihydroergotamine to Block SARS-CoV‑2 Infection”

Bibliographic Details
Main Authors: Soledad Stagnoli, Gabriele Macari, Pietro Corsi, Barbara Capone, Ander Vidaurrazaga, June Ereño-Orbea, Ana Ardá, Fabio Polticelli, Jesus Jimenez-Barbero, Nicola GA Abrescia, Ivan Coluzza
Format: Article
Language:English
Published: American Chemical Society 2024-01-01
Series:ACS Omega
Online Access:https://doi.org/10.1021/acsomega.3c10152
  • Holdings
  • Description
  • Similar Items
  • Staff View

Internet

https://doi.org/10.1021/acsomega.3c10152

Similar Items

  • Targeting the Spike: Repurposing Mithramycin and Dihydroergotamine to Block SARS-CoV‑2 Infection
    by: Soledad Stagnoli, et al.
    Published: (2023-11-01)
  • Assessing the Mobility of Severe Acute Respiratory Syndrome Coronavirus-2 Spike Protein Glycans by Structural and Computational Methods
    by: Soledad Stagnoli, et al.
    Published: (2022-04-01)
  • Nanoparticulate formulations of mithramycin analogs for enhanced cytotoxicity
    by: Scott D, et al.
    Published: (2011-11-01)
  • Mithramycin induces promoter reprogramming and differentiation of rhabdoid tumor
    by: Maggie H Chasse, et al.
    Published: (2020-12-01)
  • Mithramycin and Analogs for Overcoming Cisplatin Resistance in Ovarian Cancer
    by: David Schweer, et al.
    Published: (2021-01-01)

Search Options

  • Search History
  • Advanced Search

Find More

  • Browse the Catalog
  • Browse Alphabetically
  • Explore Channels
  • Course Reserves
  • New Items

Need Help?

  • Search Tips
  • Ask a Librarian
  • FAQs